Kruse, V., Denys, H., Van Den Broecke, R., Van Belle, S., & Cocquyt, V. (2013). The addition of bevacizumab to standard chemotherapy in breast cancer: Which patient benefits the most? Springer International Publishing AG.
Citação norma ChicagoKruse, Vibeke, Hannelore Denys, Rudy Van Den Broecke, Simon Van Belle, and Veronique Cocquyt. The Addition of Bevacizumab to Standard Chemotherapy in Breast Cancer: Which Patient Benefits the Most? Springer International Publishing AG, 2013.
Citação norma MLAKruse, Vibeke, et al. The Addition of Bevacizumab to Standard Chemotherapy in Breast Cancer: Which Patient Benefits the Most? Springer International Publishing AG, 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.